Comparison of a rapid hepatitis B immunization schedule to the standard schedule for adults

American Journal of Gastroenterology

Volumn 91, Issue 1, 1996, Pages 111-115

  Marsano, Luis S ^a   Greenberg, Richard N ^b   Kirkpatrick, Robert B ^b   Zetterman, Rowen K ^b   Christiansen, Abigail ^b   Smith, Daniel J ^b   DeMedina, Maria D ^b   Schiff, Eugene R ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SINGLE BLIND PROCEDURE;

ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SINGLE-BLIND METHOD; TIME FACTORS; VACCINES, SYNTHETIC;

EID: 0030049232     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Maynard JE. Hepatitis B: Global importance and need for control. Vaccine 1990;8(suppl):S18-S20.
2. Robinson WS. Biology of human hepatitis viruses. In: Zakim D, Boyer TD, eds. Hepatology. A textbook of liver diseases, 2nd ed. Philadelphia, PA: WB Saunders Co., 1990: 890-945.
3. The Immunization Practices Advisory Committee. Hepatitis B virus. A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40(RR-13):1-25.
4. Chen DS, Hsu NH, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-603.
5. Jilg W, Schmidt M, Deinhardt F. Vaccination against Hepatitis B: Comparison of three different vaccination schedules. J Infect Dis 1989;160:766-9.
6. Goldfarb J, Baley J, Medendorp SV, et al. Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B® hepatitis B vaccine in neonates. Pediatr Infect Dis J 1994;13:18-22.
7. Ilan Y, Nagler A, Adler R, et al. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology 1993;104:1818-21.
8. Ilan Y, Nagler A, Adler R, et al. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogenic bone marrow transplantation. Hepatology 1993;18:246-52.
9. Abraham S, Carroll MD, Najjar MF, et al. Obese and overweight adults in the United States. National Center for Health Statistics, Vital and Health Statistics. Series 11, No. 230, DHHS Pub. No. 83-1680. Public Health Service, Washington D.C.: U. S. Government Printing Office, 1983.
10. Jilg W, Schmidt M, Deinhardt F, et al. Hepatitis B vaccination. How long does protection last? Lancet 1984;2:458.
11. Nommensen FE, Go ST, MacLaren DM. Half-life of HBs antibody after hepatitis B vaccination: An aid to timing of booster vaccination. Lancet 1989;2:847-9.
12. Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14.
13. Van Hattum J, Maikoe T, Poel J, et al., In vitro anti-HBs production by individual B cells of responders to hepatitis B vaccine who subsequently lost antibody. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore: Williams and Wilkins, 1991: 774-6.
14. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-9.